Jun 1, 2021 | Clinical case

Compare your opinion with peers and Prof. Dr. Morgan Rouprêt

David is a 71-year-old amateur golfer. Despite the closing of the golf club due to the COVID-19 pandemic, he enjoys playing a game in his 8 square meter garden using a miniature golf set.

He was diagnosed with non-muscle-invasive bladder cancer (NMIBC) 3.5 years ago. Control cystoscopy 18 months ago showed again a papillary tumour. He underwent TURBT and re-TURBT.

  • Single high-grade pT1 tumour of 3.5 cm in the first resection
  • No evidence of disease after the second resection
  • BCG instillations for 1 year
  • Follow-up with cystoscopy and cytology every 3 months

Since his last follow-up 3 months ago, healthcare systems are overloaded due to the COVID-19 pandemic. The patient cannot visit the hospital due to cancelation of appointments. His next appointment can be scheduled the earliest in 2 months, which is 5 months from his last cystoscopy.
However, the urologist is concerned and the patient is anxious about delayed follow-up.

Which option would you choose as a next step for this patient?

Cast your vote and see what Prof. Dr. Morgan Rouprêt recommends for this patient case!

A
B
C

Delayed cystoscopy

Continue follow-up with cytology alone, without hospital visits

Urinary biomarker test now and, if negative, cystoscopy in 3 months; if positive, expedite the cystoscopy

Other updates

Urinary biomarkers for the surveillance of NMIBC

Can urinary biomarkers help address some of the key limitations of cystoscopy and urine cytology in the surveillance of non-muscle-invasive bladder cancer (NMIBC)? Watch this expert presentation to discover how urinary biomarkers may support a more patient-centred and...

read more